Skip to main content Help with accessibility Skip to main navigation

EMPAGLIFLOZIN tablets (Jardiance®) for treating chronic heart failure with reduced ejection fraction

CCG Approval Status:

Date Added: 15 - Oct - 2021
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of EMPAGLIFLOZIN tablets (Jardiance®) for treating chronic heart failure with reduced ejection fraction.